Dismicrobism in inflammatory bowel disease and colorectal cancer: Changes in response of colocytes

World Journal of Gastroenterology

Volumn 20, Issue 48, 2014, Pages 18121-18130

  Tomasello, Giovanni ^a   Tralongo, Pietro ^b   Damiani, Provvidenza ^c   Sinagra, Emanuele ^a,d   Di Trapani, Benedetto ^a,e   Zeenny, Marie Noelle ^b,g   Hussein, Inaya Hajj ^f   Jurjus, Abdo ^g   Leone, Angelo ^b  

^a Euro Mediterranean Institute of Science and Technology   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d Fondazione Istituto S Raffaele G Giglio Gastroenterology and Endoscopy Unit   (Italy)

^e Clinica Torina   (Italy)

^f OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^g AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Colorectal cancer; Dismicrobism; Dysbiosis; Eubiosis; Heat shock proteins; Inflammatory bowel disease

Indexed keywords

HEAT SHOCK PROTEIN; PREBIOTIC AGENT; PROBIOTIC AGENT;

AGE; AMINO ACID SYNTHESIS; ARTICLE; BACTERIAL COLONIZATION; CANCER RISK; CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CROHN DISEASE; DIET; DYSBIOSIS; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; IMMUNE RESPONSE; INTESTINE CELL; INTESTINE FLORA; INTESTINE LYMPHATIC TISSUE; INTESTINE MUCOSA; LYMPHOID TISSUE; METABOLITE; MORTALITY; NONHUMAN; STOMACH PH; ULCERATIVE COLITIS; ANIMAL; COLON; COLORECTAL NEOPLASMS; DISEASE COURSE; HOST PATHOGEN INTERACTION; INFLAMMATORY BOWEL DISEASES; MICROBIOLOGY; MICROFLORA; RISK FACTOR;

ANIMALS; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DYSBIOSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; MICROBIOTA; RISK FACTORS;

EID: 84920143213     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i48.18121     Document Type: Article

References (72)

1. Hajj Hussein IA, Tohme R, Barada K, Mostafa MH, Freund JN, Jurjus RA, Karam W, Jurjus A. Inflammatory bowel disease in rats: bacterial and chemical interaction. World J Gastroenterol 2008; 14: 4028-4039 [PMID: 18609687]
2. Margiotta G, Sanfilippo A, Accardo FM, Damiani P, Geraci A, Tomasello G. Chronic Inflammatory Bowel Disease in patients with orthopedic manifestation. Comparison with the data reported in international literauture. Euromediterranean Biomedical J 2012; 7: 33-38
3. Sobhani I, Amiot A, Le Baleur Y, Levy M, Auriault ML, Van Nhieu JT, Delchier JC. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteriarelated disease? Therap Adv Gastroenterol 2013; 6: 215-229 [PMID: 23634186 DOI: 10.1177/1756283X12473674]
4. Marchesi JR, Dutilh BE, Hall N, Peters WH, Roelofs R, Boleij A, Tjalsma H. Towards the human colorectal cancer microbiome. PLoS One 2011; 6: e20447 [PMID: 21647227 DOI: 10.1371/journal.pone.0020447]
5. Turner ND, Ritchie LE, Bresalier RS, Chapkin RS. The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis. Curr Gastroenterol Rep 2013; 15: 346 [PMID: 23949252 DOI: 10.1007/s11894-013-0346-0]
6. Tomasello G, Bellavia M, Damiano G, Gioviale MG, Lo Monte AI. Possible relation between gut microflora composition and oncogenic risk: is stimulation of inflammation the one ring of connection? Rev Med Microbiol 2012; 23: 52-57 [DOI: 10.1097/MRM.0b013e328353f49c]
7. Bettelheim KA, Breadon A, Faiers MC, O'Farrell SM, Shooter RA. The origin of O serotypes of Escherichia coli in babies after normal delivery. J Hyg (Lond) 1974; 72: 67-70 [PMID: 4593741]
8. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD, Wang J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65 [PMID: 20203603 DOI: 10.1038/nature08821]
9. Fujimura KE, Slusher NA, Cabana MD, Lynch SV. Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther 2010; 8: 435-454 [PMID: 20377338 DOI: 10.1586/ eri.10.14]
10. Tralongo P, Tomasello G, Sinagra E; Damiani P, Leone A, Palumbo VD, Giammanco M, Di Majo D, Damiani F, Abruzzo A, Bruno A, Cassata G, Cicero L, Noto M, Tomasello R, Lo Monte AI. The role of butyric acid as a protective agent against Inflammatory Bowel Diseases. Euro Biomed J 2014; 9: 24-35
11. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012; 9: 599-608 [PMID: 22907164 DOI: 10.1038/nrgastro.2012.152]
12. Hamer HM, Jonkers DM, Loof A, Vanhoutvin SA, Troost FJ, Venema K, Kodde A, Koek GH, Schipper RG, van Heerde WL, Brummer RJ. Analyses of human colonic mucus obtained by an in vivo sampling technique. Dig Liver Dis 2009; 41: 559-564 [PMID: 19213618 DOI: 10.1016/j.dld.2008.12.100]
13. Trubitsyna IE, Drozdov VN, Baryshnikov EN, Chikunova BZ, Petrakov AV. [The damaging role of endogenous nitric oxide in the development of the experimental DSS-induced colitis in rats]. Eksp Klin Gastroenterol 2010; (3): 74-77 [PMID: 20496794]
14. Yu JE, De Ravin SS, Uzel G, Landers C, Targan S, Malech HL, Holland SM, Cao W, Harpaz N, Mayer L, Cunningham-Rundles C. High levels of Crohn's disease-associated antimicrobial antibodies are present and independent of colitis in chronic granulomatous disease. Clin Immunol 2011; 138: 14-22 [PMID: 20956091 DOI: 10.1016/j.clim.2010.08.003]
15. Llopis M, Antolin M, Carol M, Borruel N, Casellas F, Martinez C, Espín-Basany E, Guarner F, Malagelada JR. Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa. Inflamm Bowel Dis 2009; 15: 275-283 [PMID: 18839424 DOI: 10.1002/ibd.20736]
16. Arseneau KO, Cominelli F. Leukocytapheresis in ulcerative colitis: a possible alternative to biological therapy? Dig Liver Dis 2009; 41: 551-552 [PMID: 19540820 DOI: 10.1016/j.dld.2009.05.014]
17. Olsen I, Tollefsen S, Aagaard C, Reitan LJ, Bannantine JP, Andersen P, Sollid LM, Lundin KE. Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients. PLoS One 2009; 4: e5641 [PMID: 19479064 DOI: 10.1371/journal.pone.0005641]
18. Grivennikov SI. Inflammation and colorectal cancer: colitisassociated neoplasia. Semin Immunopathol 2013; 35: 229-244 [PMID: 23161445 DOI: 10.1007/s00281-012-0352-6]
19. Zhu Q, Gao R, Wu W, Qin H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour Biol 2013; 34: 1285-1300 [PMID: 23397545 DOI: 10.1007/s13277-013-0684-4]
20. Saba K, Denda-Nagai K, Irimura T. A C-type lectin MGL1/CD301a plays an anti-inflammatory role in murine experimental colitis. Am J Pathol 2009; 174: 144-152 [PMID: 19095961 DOI: 10.2353/ajpath.2009.080235]
21. Gallan L. Dysbiotic relationships in the bowel. American College of Advancement in Medicine Conference; Spring 1992
22. Mitsuoka T. Intestinal Flora and aging. Nutr Rev 1992; 50: 438-446 [PMID: 1488186]
23. Knutson CG, Mangerich A, Zeng Y, Raczynski AR, Liberman RG, Kang P, Ye W, Prestwich EG, Lu K, Wishnok JS, Korzenik JR, Wogan GN, Fox JG, Dedon PC, Tannenbaum SR. Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc Natl Acad Sci USA 2013; 110: E2332-E2341 [PMID: 23754421 DOI: 10.1073/pnas.1222669110]
24. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011; 6: e16393 [PMID: 21297998 DOI: 10.1371/journal.pone.0016393]
25. Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012; 6: 320-329 [PMID: 21850056 DOI: 10.1038/ismej.2011.109]
26. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-899 [PMID: 20303878 DOI: 10.1016/j.cell.2010.01.025]
27. Rowe WA, Lichtenstein GR, Katz J. Inflammatory Bowel Disease. Medscape Drugs, Diseases and Procedures 2014. Available from: URL: http://emedicine.medscape.com/article/179037-overview
28. Fisher SA, Tremelling M, Anderson CA, Gwilliam R, Bumpstead S, Prescott NJ, Nimmo ER, Massey D, Berzuini C, Johnson C, Barrett JC, Cummings FR, Drummond H, Lees CW, Onnie CM, Hanson CE, Blaszczyk K, Inouye M, Ewels P, Ravindrarajah R, Keniry A, Hunt S, Carter M, Watkins N, Ouwehand W, Lewis CM, Cardon L, Lobo A, Forbes A, Sanderson J, Jewell DP, Mansfield JC, Deloukas P, Mathew CG, Parkes M, Satsangi J. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008; 40: 710-712 [PMID: 18438406 DOI: 10.1038/ng.145]
29. Waldner MJ, Foersch S, Neurath MF. Interleukin-6-a key regulator of colorectal cancer development. Int J Biol Sci 2012; 8: 1248-1253 [PMID: 23136553 DOI: 10.7150/ijbs.4614]
30. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904 [PMID: 20664075 DOI: 10.1152/physrev.00045]
31. Gong J, Zhang JP, Li B, Zeng C, You K, Chen MX, Yuan Y, Zhuang SM. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Oncogene 2013; 32: 3071-3079 [PMID: 22824797 DOI: 10.1038/ onc.2012.318]
32. Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 2006; 61: 575-584 [PMID: 16799139]
33. Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012; 4: 1095-1119 [PMID: 23016134 DOI: 10.3390/nu4081095]
34. Fallani M, Young D, Scott J, Norin E, Amarri S, Adam R, Aguilera M, Khanna S, Gil A, Edwards CA, Doré J. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr 2010; 51: 77-84 [PMID: 20479681 DOI: 10.1097/MPG.0b013e3181dlblle]
35. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, Mao Y, Zhang X, Pang X, Wei C, Zhao G, Chen Y, Zhao L. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 2010; 4: 232-241 [PMID: 19865183 DOI: 10.1038/ismej.2009]
36. Zimmer J, Lange B, Frick JS, Sauer H, Zimmermann K, Schwiertz A, Rusch K, Klosterhalfen S, Enck P. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr 2012; 66: 53-60 [PMID: 21811294 DOI: 10.1038/ejcn]
37. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3: 213-223 [PMID: 18407065 DOI: 10.1016/j.chom.2008.02.015]
38. Nielsen S, Nielsen DS, Lauritzen L, Jakobsen M, Michaelsen KF. Impact of diet on the intestinal microbiota in 10-monthold infants. J Pediatr Gastroenterol Nutr 2007; 44: 613-618 [PMID: 17460496 DOI: 10.1097/MPG.0b013e3180406a11]
39. Sanapareddy N, Legge RM, Jovov B, McCoy A, Burcal L, Araujo-Perez F, Randall TA, Galanko J, Benson A, Sandler RS, Rawls JF, Abdo Z, Fodor AA, Keku TO. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J 2012; 6: 1858-1868 [PMID: 22622349 DOI: 10.1038/ismej.2012.43]
40. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22: 299-306 [PMID: 22009989 DOI: 10.1101/gr.126516.111]
41. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22: 292-298 [PMID: 22009990 DOI: 10.1101/gr.126573.111]
42. O'Keefe SJ, Ou J, Aufreiter S, O'Connor D, Sharma S, Sepulveda J, Fukuwatari T, Shibata K, Mawhinney T. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J Nutr 2009; 139: 2044-2048 [PMID: 19741203 DOI: 10.3945/jn.109.104380]
43. Korzenik JR. Is Crohn's disease due to defective immunity? Gut 2007; 56: 2-5 [PMID: 17172582]
44. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569-573 [PMID: 23828891 DOI: 10.1126/science.1241165]
45. Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza F, Pallone F. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997; 112: 1169-1178 [PMID: 9098000]
46. Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith MF, Foley E, Moskaluk CA, Bickston SJ, Cominelli F. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn' s disease: expression and localization in intestinal mucosal cells. J Immunol 1999; 162: 6829-6835 [PMID: 10352304]
47. Bamias G, Martin C, Mishina M, Ross WG, Rivera-Nieves J, Marini M, Cominelli F. Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology 2005; 128: 654-666 [PMID: 15765401]
48. Davis CD, Milner JA. Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem 2009; 20: 743-752 [PMID: 19716282 DOI: 10.1016/j.jnutbio.2009.06.001]
49. Kosiewicz MM, Zirnheld AL, Alard P. Gut microbiota, immunity, and disease: a complex relationship. Front Microbiol 2011; 2: 180 [PMID: 21922015 DOI: 10.3389/ fmicb.2011.00180]
50. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009; 15: 1016-1022 [PMID: 19701202 DOI: 10.1038/nm.2015]
51. Huh JW, Lee JH, Kim HR. Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer. Arch Surg 2012; 147: 366-372 [PMID: 22508783 DOI: 10.1001/archsurg.2012.35]
52. Wu YL, Ding YP, Tanaka Y, Shen LW, Wei CH, Minato N, Zhang W. γδ T cells and their potential for immunotherapy. Int J Biol Sci 2014; 10: 119-135 [PMID: 24520210 DOI: 10.7150/ijbs.7823]
53. Todaro M, D'Asaro M, Caccamo N, Iovino F, Francipane MG, Meraviglia S, Orlando V, La Mendola C, Gulotta G, Salerno A, Dieli F, Stassi G. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol 2009; 182: 7287-7296 [PMID: 19454726 DOI: 10.4049/jimmunol.0804288]
54. Macario AJL, Conway de Macario E. The chaperoning system: physiology and pathology. In: GerbinoA, Crescimanno G, Zummo G, editors. Experimental Medicine Reviews. Anguilla: Plumelia, 2008/2009: 9-21 (ISBN 978-88-89876-15-2)
55. Macario AJ, Lange M, Ahring BK, Conway de Macario E. Stress genes and proteins in the archaea. Microbiol Mol Biol Rev 1999; 63: 923-67, table of contents [PMID: 10585970]
56. Rappa F, Farina F, Zummo G, David S, Campanella C, Carini F, Tomasello G, Damiani P, Cappello F, DE Macario EC, Macario AJ. HSP-molecular chaperones in cancer biogenesis and tumor therapy: an overview. Anticancer Res 2012; 32: 5139-5150 [PMID: 23225410]
57. van Eden W, Thole JE, van der Zee R, Noordzij A, van Embden JD, Hensen EJ, Cohen IR. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988; 331: 171-173 [PMID: 2448638]
58. Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 2001; 358: 1749-1753 [PMID: 11734230]
59. Maron R, Sukhova G, Faria AM, Hoffmann E, Mach F, Libby P, Weiner HL. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002; 106: 1708-1715 [PMID: 12270867]
60. Rha YH, Taube C, Haczku A, Joetham A, Takeda K, Duez C, Siegel M, Aydintug MK, Born WK, Dakhama A, Gelfand EW. Effect of microbial heat shock proteins on airway inflammation and hyperresponsiveness. J Immunol 2002; 169: 5300-5307 [PMID: 12391250]
61. Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario AJ. Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin. PLoS Pathog 2009; 5: e1000552 [PMID: 19714222 DOI: 10.1371/journal.ppat.1000552]
62. Tomasello G, Sciumé C, Rappa F, Rodolico V, Zerilli M, Martorana A, Cicero G, De Luca R, Damiani P, Accardo FM, Romeo M, Farina F, Bonaventura G, Modica G, Zummo G, Conway de Macario E, Macario AJ, Cappello F. Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapy. Eur J Histochem 2011; 55: e38 [PMID: 22297444 DOI: 10.4081/ejh.2011.e38]
63. Wächtershäuser A, Stein J. Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr 2000; 39: 164-171 [PMID: 11079736]
64. Zoran DL, Barhoumi R, Burghardt RC, Chapkin RS, Lupton JR. Diet and carcinogen alter luminal butyrate concentration and intracellular pH in isolated rat colonocytes. Nutr Cancer 1997; 27: 222-230 [PMID: 9101550]
65. Basson MD, Liu YW, Hanly AM, Emenaker NJ, Shenoy SG, Gould Rothberg BE. Identification and comparative analysis of human colonocyte short-chain fatty acid response genes. J Gastrointest Surg 2000; 4: 501-512 [PMID: 11077326]
66. Myzak MC, Dashwood RH. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr Drug Targets 2006; 7: 443-452 [PMID: 16611031]
67. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr 2003; 133: 2485S-2493S [PMID: 12840228]
68. Shenderov BA. Gut indigenous microbiota and epigenetics. Microb Ecol Health Dis 2012; 23: 17195 [PMID: 23990811 DOI: 10.3402/mehd.v23i0.17195]
69. Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 2004; 229: 586-597 [PMID: 15229352]
70. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012; 338: 120-123 [PMID: 22903521 DOI: 10.1126/science.1224820]
71. Piazzi G, D'Argenio G, Prossomariti A, Lembo V, Mazzone G, Candela M, Biagi E, Brigidi P, Vitaglione P, Fogliano V, D'Angelo L, Fazio C, Munarini A, Belluzzi A, Ceccarelli C, Chieco P, Balbi T, Loadman PM, Hull MA, Romano M, Bazzoli F, Ricciardiello L. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitisassociated colorectal cancer acting on Notch signaling and gut microbiota. Int J Cancer 2014; 135: 2004-2013 [PMID: 24676631 DOI: 10.1002/ijc.28853]
72. Andersen AD, Molbak L, Michaelsen KF, Lauritzen L. Molecular fingerprints of the human fecal microbiota from 9 to 18 months old and the effect of fish oil supplementation. J Pediatr Gastroenterol Nutr 2011; 53: 303-309 [PMID: 21865979 DOI: 10.1097/MPG.0b013e31821d298f]